KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
2.590
-0.020 (-0.77%)
At close: Mar 28, 2025, 4:00 PM
2.677
+0.087 (3.35%)
After-hours: Mar 28, 2025, 5:14 PM EDT
KORU Medical Systems Revenue
In the year 2024, KORU Medical Systems had annual revenue of $33.65M with 17.98% growth. KORU Medical Systems had revenue of $8.84M in the quarter ending December 31, 2024, with 23.00% growth.
Revenue (ttm)
$33.65M
Revenue Growth
+17.98%
P/S Ratio
3.53
Revenue / Employee
$420,581
Employees
80
Market Cap
119.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.65M | 5.13M | 17.98% |
Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKRMD News
- 17 days ago - KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance - Business Wire
- 5 weeks ago - KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 - Business Wire
- 6 weeks ago - KORU Medical Systems Has A Long Runway - Seeking Alpha
- 7 weeks ago - KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System - Business Wire
- 2 months ago - KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Business Wire
- 2 months ago - KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter - Business Wire
- 4 months ago - KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference - Business Wire